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Origin of hypercholesterolemia in chronic experimental nephrotic
syndrome. Sixteen nephrotized rats and eight controls were sub-
mitted to a continuous sterol balance for two weeks. During the
whole experiment (two months) the rats were pair-fed a balanced
sterol-free diet and their proteinuria regularly measured as a pa-
rameter of the nephrotic state. Serum cholesterol and albumin
were also measured at the end of the experiment Liver and carcass
(excluding intestine and central nervous system) as well as feces
were submitted to sterol analysis by gas-liquid chromatography.
Sterol losses were corrected for by adding radioactive cholesterol
and cholic acid at the beginning of the methodological procedures.
The results showed that while fecal sterol excrel ion was similar in
the nephrotic group as compared to controls, a Jefinite increase in
serum, carcass, and liver cholesterol was observcd in the nephrotic
animals, indicating that a real enhancement of synthesis had oc-
curred. The meaning of increased cholesterol hepatic content is
discussed, as well as the possible relationship between enhanced
protein and cholesterol hepatic synthesis.
Origine de l'hypercholestérolémie dans le syndrome néphrotique
chronique experimental. Seize rats rendus néphrotiques et huit rats
contrôles ont été soumis a une étude continue du bilan des stérols
pendant deux semaines. Pendant toute Ia durée de l'expérience
(deux mois) des paires de rats ont été alimentés avec un régime
équilibré dépourvu de stérols et leur protéinurie a été régU-
lièrement mesurée et considérée comme un paramètre de l'état
néphrotique. L'albumine et le cholesterol sériques ont été mesurés
a Ia fin de l'expérience. Le foie et le cadavre (a l'exclusion de
l'intestin et du système nerveux central) de même que les selles ont
été soumis a l'analyse des stérols par chromatographie gazeuse en
veine liquide. Les pertes de stérols ont été corrigCes par l'addition
de cholesterol radioactif et d'acide cholique an debut des étapes
methodologiques. Les résultats montrent qu'alors que l'excrétion
fécale de stérols est semblable dans les groupes néphrotique et
contrôle, une augmentation importante de Ia concentration de cho-
lestérol dans le foie et le cadavre est observée chez les animaux
nephrotiques, cc qui indique qu'une augmentation certaine de Ia
synthese est intervenue. La signification de l'au&mentation du con-
tenu hépatique en cholesterol est discutée de méme que Ia relation
possible entre les accroissements des syntheses hépatiques de pro-
téine et de cholesterol.
In the past years several hypotheses trying to ex-
plain the hyperlipemia and the hypercholesterolemia
of the nephrotic syndrome have been put forward.
Some authors have related this disturbance to de-
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creased thyroid function [1, 2, 3], but thyroxine ad-
ministration does not correct elevated serum lipid
levels [2]. Moreover, hypothyroidism is not a com-
mon feature in the nephrotic syndrome [4, 5]. Other
authors have proposed an impaired tissue removal of
lipids due to decreased lipoprotein lipase activity [6]
that may be secondary to urinary loss of lipoprotein
lipase [7]. Furthermore, the i.v. infusion of dextran
and other macromolecules is as effective as albumin
in reducing nephrotic hyperlipidemia [8], without
correcting the serum albumin level. As these sub-
stances are not fatty acid carriers [81, impaired fatty
acid transport secondary to low albumin values can-
not be evoked to explain the primary cause of high
serum lipid levels in the nephrotic syndrome [3].
On the other hand, by means of isotopic methods,
evidences have been presented for lowered [9, 10],
increased [10,11,12], and normal [13,14] rates of lipid
synthesis. Nevertheless, no clear cut explanation can
be drawn from these experiments using radiolabeled
precursors such as acetate, because the size of the
precursor pool was unknown or compartmental dis-
tribution was not considered.
The i.v. use of labeled products, such as radio-
cholesterol, was not satisfactory either since its pre-
cise rate of distribution in the tissues, a condition
critical to the analysis of the data, is unknown [15].
Nevertheless, the cholesterol molecule does not enter
other significant metabolic pathways, except for its
transformation into bile acids, and is recovered quan-
titatively from animal tissues and excreted material
[16, 17]. Thus, animal sterol balance studies are ideal
to identify the nature of the disturbance of the serum
cholesterol that occurs in the nephrotic syndrome.
In this paper the quantitative measurement of tis-
sue cholesterol was carried out in rats made nephrotic
by anti-rat kidney serum and in controls. Feces were
also measured by means of the balance technique [18,
19] with the animals kept on a sterol-free diet. There-
fore, by excluding participation of dietary cholesterol
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absorption, it was possible to know whether the
hypercholesterolemia in nephrotic rats was due to an
increased body synthesis, compartmental redistribu-
tion, or impaired fecal steroid excretion.
Methods
Male rats of Wistar origin, weighing from 90 to 100
g, were placed in individual metabolic cages and fed a
sterol-free diet containing 4 calories/g during the
pre-experimental week and throughout the induc-
tion of nephrosis and sterol balance period. The
dietary composition by weight was 42% casein, 46%
starch, 2.5% pure linoleic acid, and 9.5% mineral
salts, vitamins, and methyl cellulose. The average
daily intake during the whole experiment (two
months) provided approximately 200 mg of linoleic
acid, which is three to four times the minimum re-
quirement [20]. The diet contained only l4izg of ster-
ols/g as shown by gas-liquid chromatographic analy-
sis (GLC).
Experimental nephrosis. Twenty-four rats were in-
vestigated, and sixteen were randomly chosen for the
production of the experimental nephrosis (mem-
brano-proliferative glomerulonephritis) according to
the technique of Heymann and Lund [21]. A small
volume of serum was injected at regular intervals to
induce a mild form of the disease. Enough anti-rat
kidney serum was injected to obtain a proteinuria of
at least 5 mg/hr without eliciting diarrhea, ascites, or
apparent edema. No deaths occurred during the ex-
perimental period. About two weeks of treatment
were required to obtain the desired degree of neph-
rosis which was maintained throughout the ensuing
experimental period. Nephrosis was controlled by
daily analysis of the urinary protein excretion by the
biuret method [22] and characterized at the end of the
experiment by measuring serum cholesterol [23], to-
tal serum proteins [22], and serum albumin by elec-
trophoresis on Cellogel (Chemetron, Milan, Italy).
Balance technique. After the attainment of ade-
quate proteinuria, the rats were submitted to a 15 to
20-day continuous and complete fecal collection. As
rats were fed on solid diet, no correction for sterol
losses was necessary [24]. The experiment ended by
exsanguinating the animals through aortic puncture
during light ether anesthesia. Central nervous system
and intestine were excluded from analysis since the
nervous system is rich in cholesterol which behaves as
an independent pool [25], and fecal contamination in
the intestine is expected. The liver was separated from
the remaining carcass.
Analytical procedures. Carcass, liver, and feces
were analyzed separately. Tissues were digested by
refluxing at 110°C on sodium hydroxide solution
(aqueous for carcass, and ethanolic for liver and
feces); sterols were determined by GLC [18, 19].
Methodologic procedures were tested before their use
on experimental samples, and variable losses of ap-
proximately 30% were observed. Thus, cholesterol-4-
'4C (New England Nuclear, Boston, MA) was added
prior to hydrolysis to correct for neutral steroid
losses, and l,2-3H cholic acid (New England Nuclear,
Boston, MA) was also added to the aliquots of fecal
samples to correct for bile acid losses during the
analytical procedure.
Results
Considering the difficulty of controlling the weight
of nephrotic rats since they might develop some de-
gree of unnoticed edema and ascites, we resorted to
pair-feeding both groups. Accordingly, the daily
dietary intake was 7.9 g/rat during the whole experi-
ment, which permitted continuous weight gain that
was similar in nephrotic and control animals. Thus,
the final body wt was similar in both groups; how-
ever, the carcasses were slightly heavier in control
animals. Such a difference could have been due to a
small amount of ascites in addition to a conceivable
intestinal wall edema, besides the heavier liver in the
nephrotic animals. Data on dietary intake and body
wt are summarized in Figure 1.
The nephrotic state was identified by measuring
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Fig. 1. Daily dietary intake during the experiment and weights of
liver, carcass, and the animal at the end of the experiment. Values
represent means SD of the nephrotic (N = 16) and control (N =
8) groups. The astericks (*) mean that the statistical difference
between both groups were significant at P < 0.01.
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Fecal steroid output in nephrotics was equal to
controls. As steroid excretion, however, represents a
fixed fraction of cholesterol body mass [27], which is
increased in the nephrotic animal, a relative impair-
ment of steroid excretion may be present.
Previous studies dealing with cholesterol in the
nephrotic syndrome suggest there is a removal defect
in peripheral tissues [11] or in liver [28] as well as an
enhanced body production [11, 12]. Our finding of
increased tissue cholesterol mass rules out a removal
impairment as the primary cause of hypercholestero-
lemia. In the more severe stages of the disease, how-
ever, an association with impaired peripheral re-
moval of triglycerides due to very low serum albumin
concentrations cannot be ruled out [29, 30].
Thus, enhanced hepatic production of cholesterol
must be evoked to explain the increased values of
cholesterol in the whole rat.
The comprehension of sterol metabolism in the
liver, however, is more complex. Previous authors
[31, 32] have shown that feeding cholesterol increases
its content in the normal rat liver, interrupts choles-
terol synthesis by a feedback mechanism, and leads to
enhanced bile acid output. On the other hand, in the
Table I. Tissue cholesterol anti fecal steroid data in nephrotic
and control ratsa
Serum cholesteroi
mgi 100 ml
___________
Serum protein, g/100 ml
______________
Totil
Proteinuria
mg/day 300 6 -
4 . AIbuming/lOO ml
2-
200 200
Control
100 100
Nephrotic
Fig. 2. Nephrotic state of the anti-rat kidney serum injected rats, as
measured by daily proteinuria. serum cholesterol, and serum albu-
min. Values represent means SD in the nephrotic (N = 16) and
control (N = 8) groups. The astericks (*) mean that the statistical
difference between both groups were significant st P < 0.001.
urinary protein, serum cholesterol, and serum pro-
tein, as shown in Figure 2. Since caloric intake was
identical in both groups, it is conceivable that the
greater urinary loss of protein in the nephrotic rats
might represent a substantial waste of calories. Con-
sidering urinary protein output in calories during the
whole experiment, however, the differences between
both groups amount to approximately 27 calories/
month, namely only 2.5% of the total caloric
intake.
Tissue cholesterol and fecal steroid balance data
are presented in Table 1. Urinary sterols were ex-
cluded from calculation because they represented
only 75 to 300tg/day as measured by GLC [19] and
were identical in both groups. Table 1 shows a defi-
nite increase in liver and plasma cholesterol of neph-
rotic rats. Cholesterol level in the nephrotic carcass is
higher than in controls only when expressed as
mg/lOO g, because carcass weight in the nephrotic
group is significantly lower (Fig. 1). Even without the
necessary correction for carcass weight, the analysis
of whole body cholesterol shows it is increased in
nephrotics as compared to controls.
Discussion
Nephrotic hypercholesterolemia may theoretically
derive from: 1) increased intestinal absorption of
cholesterol, 2) diminished fecal steroid output, 3) pe-
ripheral removal defect, 4) enhanced hepatic produc-
tion.
In our work, animals were fed a sterol-free diet.
Thus, increased intestinal absorption of cholesterol
can be safely ruled out.
Control group(iV=8) Nephrotic group(N=16)
Carcass
mg/IOOgb 155.8 10.3 183.2 25.8
mg/carcass 201,0± 14.6 204.5± 30.6
Liver
mg/bOg" 243.9+45.0 349.6± 107.3
mg/liverb 15.6 3.6 29.9 + 7.2
Plasma
mg/bOOgb 64.6 7.9 325.3 44.8
mg/total plasma' 4.1±0.5 20.6±4.1
Whole bodyc
mg/bOOgb 156.4+ 13.5 202.5±23.7
mg/ratb 212.9 + 16.7 259.2 + 40.7
Neutral fecal steroids
mg/bOO g/day/BW'1 2.7 + 0.6 3.0 0.7
mg/day 3.7 0.8 3.7 1.0
Fecal bile acids
mg/bOO g/day/BWd 4.1 + 0.7 4.5 + 1.5
mg/day 5.6 + 1.0 5.4 1.6
Numbers represent means SD.
Nephrotic and control groups 'were significantly different accord-
ing to Student's t test at 1% level or higher.
Whole body means the sum of carcass, liver, and plasma choles-
terol. Plasma weight was calculated as 4.5% of final body weight
(BW) before sacrifice [26].
Body weight is expressed as the sum of carcass and liver only.
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nephrotic animals, in spite of the increased hepatic
content, the cholesterol feedback mechanism is oper-
ative [9], and enhanced bile acid output does not
occur [33] (Table I). These findings strongly suggest
that the excess of cholesterol produced is being stored
in a pooi different from the production site within the
hepatocyte of nephrotic rats.
The relationship between increased cholesterol
synthesis and the changes in protein metabolism
should also be discussed, At present, data indicate
that, in experimental nephrosis, peripheral amino
acids are channeled into hepatic protein synthesis
[10]. being simultaneously diverted from hepatic
gluconeogenesis [34]. Furthermore, liver glycolysis
being depressed in the nephrotic state allows a greater
contingent of precursors for protein and lipid syn-
thesis [34] and conforms to the pattern of enhanced
albumin production in the liver [10, 35, 36] elicited by
lowered serum oncotic pressure [35, 37]. The in-
creased availability of the lipoprotein peptide moiety,
acting as the trigger of enhanced cholesterol syn-
thesis, becomes an interesting working hypothesis,
emphasizing the connection between protein and
lipid metabolism.
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